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ABSTRACT.  Recent technological advances that now permit us to detect gastroesophageal reflux (GER),
independent of pH, have sparked a fury of interest in non-acid GER as a potential culprit in respiratory
disorders. Application of combined esophageal pH and multichannel intraluminal impedance (MII)
monitoring to the study and diagnosis of GER disease (GERD) demonstrated non-acid GER to be far more
frequent (in infants, children, and adults alike) than previously recognized. The following report is a
review of the current literature that describes non-acid GER or that temporally associates non-acid GER
with respiratory disorders.
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Respiratory symptoms associated with GER have been
previously described (Harding and others 1999; Wenzl
and others 1999; Wenzl and others 2001; Rosen and
Nurko 2004; Blondeau and others 2004). While relief of
respiratory symptoms for some patients is achieved
through acid suppression therapies (Meier and others
1994; Harding and others 1996; Teichtahl and others
1996), many patients continue to have respiratory symp-
toms that could be attributed to GER (Meier and others
1994; Harding and others 1996; Gustafsson and others
1992; Kiljander and others 1999; Garrigues and others
2003; Bowrey and others 2000). These data, in conjunc-
tion with previous studies that indicate that anti-reflux
surgery produces dramatic relief of respiratory symp-
toms (Kennedy 1962; Overholt and Voorhees 1966; Davis
and Fiuzat 1967; Skinner and Belsey 1967; Urschel and
Paulson 1967; Babb and others 1970; Lomasney 1977;
Henderson and Woolfe 1978; Pellegrini and others
1979), support a possible role for non-acid reflux in
the persistence of respiratory symptoms following acid
suppression therapy in children with acid GER.
One of the first studies linking non-acid GER with
respiratory disorders came in the late 1990s when Wenzl
and others (1999) reported that 88% of the total GER
in infants (mean age at study, 69 ± 38 days) with either
recurrent regurgitations or respiratory symptoms were
non-acid. Their data also showed that, of the total GER
episodes that were temporally associated with breath-
ing irregularities, 78% were non-acid. In a later report,
this same group reported a significant correlation be-
tween the time spent apneic and the time spent in
reflux in the same population of infants (Wenzl and
others 2001). We reported that in infants (median age at
the time of study, 3 months, range 1 to 17 months) with
recurrent episodes of apparent life threatening events
(ALTEs) and respiratory disorders, 48% of the total GER
episodes were non-acid and 41% of the episodes that
were temporally associated with apnea were non-acid
(Mousa and others 2005a). Rosen and Nurko (2004)
reported that in children (mean age at the time of the
study, 6.5 ± 5.6 years) with respiratory symptoms that
include coughing, desaturations, tachypnea, wheezing,
breath holding, and grunting, 45% of the total GER
episodes were non-acid. Their data also indicated that
respiratory symptoms within their patient population
occurred significantly more often when the temporally
associated GER are non-acid, mixed (both liquid and
gas), and reached the proximal esophagus.
In adults, non-acid GER has been temporally asso-
ciated with chronic coughing. In a study of 15 patients
with chronic cough, Blondeau and others (2004) identi-
fied 7 patients who had positive symptom association
probabilities (SAP) between GER and coughing. Five of
the 7 (71%) had positive SAPs between non-acid GER
and coughing. The authors suggest that coughing within
this sub-population of chronic coughers may be induced
by a component(s) of the non-acid GER or by reflux-
induced esophageal distension.
Non-acid GER may also have an impact on asthma. In
one of the first studies to report a correlation between
asthma symptoms and esophageal acid events in
asthmatics with GER, Harding and others (1999) found
that 28% of asthmatics with reflux symptoms had normal
esophageal pH tests. While there is currently very little
data on non-acid GER and its effect(s) on the lung,
anecdotal evidence suggests a possible role for non-acid
GER in patients whose asthmatic symptoms were re-
sistant to acid suppression therapy but were relieved
following anti-reflux surgery (Garrigues and others
2003). A review of the literature suggests that studies
employing the use of combined pH and MII techniques
to test any possible link between non-acid GER and
asthma are lacking.
Animal models have provided significant insight
regarding the possible effects of microaspiration on in-
creased airway reactivity secondary to reflux. Colombo
and Hallberg (2000), for example, found that repeated
small volume aspiration of milk (such as might occur in
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non-acid GER) in rabbits causes persistent inflammation
and is associated with greater airway reactivity when
compared to saline controls. Inflammation was accom-
panied by increased neutrophils, eosinophils, and acti-
vated (binucleate) alveolar macrophages in bronchial
lavage specimens. This study supports a hypothesis for
the possible role of non-acid GER in persistent respira-
tory symptoms and asthma via microaspiration.
Mechanisms of Non-Acid GER-Induced Peptic
Symptoms
Due to the juxtaposition of both the trachea and the
esophagus, the respiratory tract is particularly vulnerable
to proximal esophageal refluxates that reach the pharynx.
Two mechanisms for the pathogenesis of acid GER-
induced respiratory symptoms have been proposed. The
first, termed the “reflux theory,” proposes that respiratory
symptoms are the result of micro-aspiration of gastric
contents into the lungs and/or bronchia. The second,
called the “reflex theory,” proposes that constriction or
collapse of bronchial tubes is a vagus nerve-mediated
event that follows acidification of the lower esophagus
(Garrigues and others 2003).
The relatively few studies that have investigated po-
tential mechanisms for non-acid GER-induced path-
ologies suggest a possible vagus nerve-mediated effect
involving esophageal distension (a reflex response), a
micro-aspiration effect (a reflux response), and possibly
a role for a component(s) of the non-acid gastric fluid
(a potential reflex and reflux response) (Rosen and
Nurko 2004; Blondeau and others 2004). Regarding the
later, bile acids have been proposed as a possible
inflammation-promoting component of non-acid fluids.
Several studies, conducted both in vivo and in vitro,
demonstrate that non-acid GER containing bile has a
damaging effect on esophageal and laryngeal tissues
(Galli and others 2002; Shirvani and others 2000; Sung
and others 2003). Wynne and others (1981) used scan-
ning electron microscopy to show that, while mild in
comparison to gastric juice or hydrochloric acid solu-
tions at pH 1.5, cellular loss also occurs following ex-
posure of rat tracheal mucosa to gastric juice at pH 5.9.
Tobey and others (1996) used transmission electron
microscopy to examine the epithelium of esophageal
biopsy specimens from patients with erosive reflux, non-
erosive reflux, and non-GERD controls. Their data
showed that both erosive reflux and non-erosive reflux
specimens contained dilated intracellular spaces whose
measurements were both significantly larger than non-
GERD controls. Fractionization studies involving the
testing of individual gastric fluid fractions would likely
facilitate identification of specific pathologic effects of
different non-acid GER components.
There is a growing body of evidence to suggest that
both acid and non-acid GER behave similarly and, there-
fore, both should be considered when attempting to
correlate supraesophageal disorders with reflux (Gus-
tafsson and others 1992; Meier and others 1994; Harding
and others 1996; Kiljander and others 1999; Wenzl and
others 1999; Bowrey and others 2000; Garrigues and
others 2003; Rosen and Nurko 2004)
Pathophysiology of Non-Acid Reflux
Using combined manometry/pH/MII measurements,
Sifrim and others (2001a) showed that transient lower
esophageal sphincter relaxations (TLESRs) were the most
common motor event underlying non-acid reflux; TLESRs
accounted for 80% of non-acid GER in normal subjects
and 55% of non-acid GER in symptomatic subjects.
Proximal Migration of Non-Acid GER
For acid GER, the proximal extent of the refluxate is
considered to be risk factor for symptom generation in
patients with GERD (Weusten and others 1995). Using
combined pH/MII measurements, both stationary and
ambulatory studies have shown that 34 to 48% of acid
GER compared to 21 to 29% of non-acid GER reached
the proximal esophagus (Sifrim and others 2001b; Shay
and others 2004). However, in another study, Vela and
others (2001) found no significant difference in the
median height reached by either refluxate; 64% of acid
GER and 57% of non-acid GER reached the proximal
esophagus. Further investigation is required to clarify
this difference in findings between the two groups.
Esophageal Clearance of Non-Acid GER
Esophageal volume clearance of non-acid GER is
slightly faster than acid GER in adults. This difference
was seen in healthy (Shay and others 2004) and in
symptomatic adults (Sifrim and others 2001c). Our
studies have detected no significant difference in the
volume clearance of acid and non-acid GER in symp-
tomatic children (Mousa and others 2005b).
Frequency of Non-Acid GER
The ratio of acid to non-acid GER fluctuates through-
out the course of the day, in both control and in patients
with reflux disease, as it is largely influenced by feeding.
In adults, non-acid reflux is more likely to occur 30
minutes after a meal (due to the buffering effects of
foods) and acid reflux occurs about an hour later
(Sifrim and others 2001a). In children, non-acid reflux is
more likely to occur during feeding and the first post-
prandial hour (Mousa and others 2005b).
The prevalence of acid and non-acid reflux has
recently been tested in adults using ambulatory pH/MII
monitoring. In the first study of 30 patients with symp-
toms of GERD and erosive esophagitis and 28 controls,
both fed a standard liquid diet, Sifrim and others (2001b)
found that 65% of the GER in controls was non-acid
compared to 54% in symptomatic subjects. In a later
study of 30 symptomatic subjects and 20 controls, both
fed their normal/habitual solid-liquid meal com-
bination, Sifrim and others (2002) found similar results;
54% of the total GER episodes in controls were non-
acid compared to 38% of GER events in symptomatic
subjects. In a more recent multicenter study of 60
normal volunteers who were permitted to eat their
normal diet, Shay and others (2004) found that the
frequency of acid reflux was twice that of the non-acid
reflux. Further investigation is required to clarify these
findings.
114 VOL.  106GER AND RESPIRATORY DISORDERS
The Ratio Between Acid and Non-acid Reflux
is Influenced by Gastric Emptying
Combined pH/MII measurements have shown that
while the rate of gastric emptying does not appear to
influence the total number of GER episodes, it does in-
fluence the proportion of post-prandial acid and non-
acid GER (Sifrim 2004). The data indicate that in adults,
when the rate of gastric emptying is slow, the number
of post-prandial non-acid GER episodes is higher. Con-
versely, when the rate of gastric emptying is fast, the
number of post-prandial acid GER episodes is higher
(Sifrim 2004). A study examining the impact of delayed
gastric emptying on gastroesophageal reflux disease
(GERD) found that the incidence of esophagitis in
GERD patients with delayed gastric emptying was sig-
nificantly lower than those with normal emptying
(Schwizer and others 1989). This observation was ex-
plained by the protracted buffering capacity of meals in
patients with slower gastric emptying (Schwizer and
others 1989).
Non-Acid GER and Peptic Symptoms
Following discontinuance of proton-pump inhibitors
in patients with GERD, Vela and others (2001) found
that patients reported heartburn, acid taste, and regur-
gitation during both acid and non-acid GER. Among the
symptoms associated with non-acid GER, heartburn
episodes were twice as frequent as regurgitation events.
A review of the literature, with all of its contradictions,
shows that the mechanism(s) by which non-acid GER
induces heartburn is as yet very poorly understood
(Smout 1997; Fass and Tougas 2002).
In another study, Sifrim and others (2002) found that
only 12% of 200 heartburn episodes reported from
among 30 patients were temporally associated with
non-acid GER. Interestingly, when GERD subjects were
treated with omeprazole, while acid GER was drastically
decreased, the normally predominant symptom heartburn
became replaced with regurgitation as the dominant
symptom (Vela and others 2001).
Treatment of Non-acid GER
The growing body evidence supporting an involve-
ment of non-acid GER in respiratory disorders necessi-
tates the need for development of treatment strategies
aimed at either reducing the number of non-acid GER
or impeding its proximal migration within the esophagus.
Baclofen : Studies in animals have shown that bac-
lofen (Lehmann and others 1999, 2000; Staunton and
others 2000) and other γ-amino-butyric acid (GABA
B
)
receptor agonists (Blackshaw and others 1999) are effec-
tive at reducing the number of TLESRs, the predominant
mechanism for both acid and non-acid GER (Sifrim and
others 2001a). In two recent studies that evaluated the
effect of a GABA
B
 receptor agonist on TLESRs in
humans, baclofen was shown to effectively reduce the
number of both acid and non-acid reflux events (Vela
and others 2003; Koek and others 2003).
Prokinetics : It has been suggested that prokinetic
medications might possibly have the potential to reduce
the amount of non-acid reflux although to date none
have been evaluated for this purpose (Rosen and Nurko
2004). They have been useful in the treatment of motility
disorders in humans and in animals because they induce
coordinated motility patterns. The data show that cisa-
pride, for example, enhances antro-duodenal coordin-
ation and gastric emptying (Fraser and others 1993),
stimulates propulsive motility patterns in the human
jejunum (Coremans and others 1988), accelerates in-
testinal transit (Fraser and others 1993), and increases
lower esophageal sphincter pressure (Smout and others
1985). Metoclopramide is another popular prokinetic
drug that hastens stomach emptying of solid and liquid
meals into the small intestines. And, like cisapride,
metoclopramide increases muscle tone in the lower
esophageal sphincter. Rapid emptying of meals, coupled
with a tighter LES, could potentially help to decrease
non-acid reflux. Anticholinergic compounds such as
atropine have been shown to decrease the number of
GER episodes by decreasing the number TLESRs (Lidims
and others 1998), further supporting the notion that phar-
macological control of reflux through control of TLESRs
is possible. A review of the literature shows that pro-
kinetics, in general, have yet to be tested for their
potential effects on non-acid GER.
Proton Pump Inhibitors : The data show that treatment
with proton pump inhibitors such as omeprazole results
in a striking decrease in the amount of post-prandial
acid GER with continued post-prandial regurgitation of
non-acid GER. There was no significant change in the
total number of post-prandial GER episodes (both acid
and non-acid) following acid-suppression therapy (Vela
and others 2001).
Sodium Alginate : While not effective at reducing the
number of non-acid GER, sodium alginate appears to
limit the proximal migration of reflux events so as to
reduce the number of supraesophageal manifestations
of GER (hoarseness, chronic cough, asthma, and so
forth) (Zentilin and others 2005).
Formula Thickening : Thickened formula feedings is
another therapeutic approach aimed at reducing the
frequency and volume of regurgitation (Vandenplas
and others 1998a,b; Rudolph and others 2001; Carroll
and others 2002; Wenzl and others 2003). Rice cereal
and bean gum are both used as thickening agents in
dietary preparations. However, while rice is broken
down by starch-specific enzymes in the saliva, bean
gum is not and therefore maintains its thickening
potential even after reaching the stomach (Vandenplas
and others 1998b; Wenzl and others 2003). While not
having any significant effect on the frequency of acid
GER, formula thickening has been shown to reduce the
number and the proximal extent of non-acid GER
(Wenzl and others 2003).
Surgical Management : Fundoplication has been the
standard surgical method for treating GER that is re-
fractory to medical therapy. During this procedure, the
fundus is gathered, wrapped, and then sutured around
the LES. The resulting “plication” produces an increase
in the pressure at the LES, which reduces the frequency
of transient LES relaxations (Ireland and others 1993;
Little 1992) and enhances gastric emptying (Hinder and
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others 1989). Fundoplication reduces the frequency and
volume of GER independent of the pH of the refluxate.
SUMMARY AND CONCLUSIONS
Non-acid GER occurs considerably more often than
previously recognized and is particularly frequent in
patients treated with proton pump inhibitors. Non-acid
GER constitutes as little as one-third and as much as
two-thirds of the total daily GER among symptomatic
and healthy controls.
There are preliminary data to suggest that there may
be some causal relationship between non-acid GER
and various respiratory disorders. As these causal rela-
tionships remain presently controversial (for example,
GER and apnea in infants), further investigation is
needed to confirm or reject non-acid GER as the cause
of an associated disorder.
Combined pH/MII monitoring will allow investigators
to obtain a more complete and thorough understanding
of their patient’s GER characteristics, hopefully leading
to improved patient care.
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